Immuno Oncology Summit
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
552 Massachusetts Ave Ste 204, Cambridge...Phone Number
(857) 209-4097Revenue
$6 MillionIndustry
About Immuno Oncology Summit
Is Immuno Oncology Summit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Immuno Oncology Summit recently announced quarterly report
Product Launch: Get notified when Immuno Oncology Summit launches new products
Check if Immuno Oncology Summit has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Immuno Oncology Summit, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Immuno Oncology Summit is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Immuno Oncology Summit has new funding data
Click to see if Immuno Oncology Summit had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Immuno Oncology Summit
Recommended Actions
Reach out to Masked Content who joined Immuno Oncology Summit as Masked Content
Find more new buyers
Compare Similar Companies to Immuno Oncology Summit
Compare insights from companies similar to Immuno Oncology Summit, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immuno Oncology Summit
Immuno Oncology Summit Tech Stack
A closer look at the technologies used by Immuno Oncology Summit
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Immuno Oncology Summit
Immuno-Oncology Summit is a professional conference series produced by Cambridge Healthtech Institute, headquartered in Needham, Massachusetts. The event showcases preclinical and clinical studies focused on the development of therapeutics for solid tumors, with specific coverage of bi/multispecific antibodies, antibody-drug conjugates, CAR-T thera... Read More